FUJIFILM India Launches Digital X-Ray Facility in Dholera

FUJIFILM India, a worldwide leader in healthcare technology, has opened an advanced digital radiology X-Ray facility at the Community Health Centre (CHC) in Dholera. This initiative, part of the company's CSR initiative, is intended to address...

Zydus, Pinkathon Launch 10th Mumbai Run for Awareness

Pinkathon, India's largest women's run, and Zydus Lifesciences Ltd., a global healthcare organization driven by innovation, announced the 10th Mumbai Pinkathon, which would take place at MMRDA Grounds, BKC, on December 21, 2025. Zydus has partnered

Govt Bans 34 Antimicrobials for Use in Animals

In a significant move to combat antimicrobial resistance, the Union Health Ministry has banned the import, manufacture, and sale of 34 antimicrobials and their formulations for use in animals

Alembic Pharma Gets USFDA Nod for Paroxetine ER Tablets

Alembic Pharmaceuticals Limited has announced today that it has obtained final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) pertaining to Paroxetine Extended-Release Tablets USP...

Organon Backs Women Repro Health on Contraception Day

In order to emphasize the vital significance of fair access to contraceptive and reproductive health services across the Asia Pacific area, Organon, a worldwide healthcare organization dedicated to women's health, is working with regional partners

Torrent Gets South Africa's Nod for JB Pharma Acquisition

The Competition Commission of South Africa approved Torrent Pharmaceuticals' acquisition of a majority interest in JB Chemicals & Pharmaceuticals from international investment firm KKR on September 22, 2025, giving the company a major boost in its

Tata 1mg draws investor interest amid valuation standoff

Novo Holdings, which is the principal stakeholder in Danish developer of diabetes and obesity medications, Novo Nordisk, alongside Canadian pension fund CPPIB, Permira and Chrys Capital, has expressed an appetite to invest into Tata Group's online

Intas Launches HETRONIFLY, Breakthrough PD-1 Therapy in ES-SCLC

Intas Pharmaceuticals launches HETRONIFLY (Serplulimab) in the Indian market, the world's first PD-1 inhibitor to be approved for use in Extensive-Stage Small Cell Lung Cancer (ES-SCLC). This launch is a significant step following its previous...

Siemens India Launches Campaign to Ease Scan Anxiety

In order to reduce Scanxiety the elevated feelings of anxiety, dread, or distress that people may have prior to, during, and following a medical imaging scan ,Siemens Healthineers in India launched the "Knowing is Comforting" campaign.

Indoco Passes USFDA Inspection with Zero Observations

Indoco is a pharmaceutical company with a large global presence that is completely integrated and focused on research. With a human capital of over 6000 personnel, including over 400 highly qualified scientists and field workers who represent the

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.